EP0697293A1 - New organic solvent for microcapsules useful notably for pressure-sensitive copy paper and pressure-sensitive copy coated with such microcapsules - Google Patents

New organic solvent for microcapsules useful notably for pressure-sensitive copy paper and pressure-sensitive copy coated with such microcapsules Download PDF

Info

Publication number
EP0697293A1
EP0697293A1 EP95401746A EP95401746A EP0697293A1 EP 0697293 A1 EP0697293 A1 EP 0697293A1 EP 95401746 A EP95401746 A EP 95401746A EP 95401746 A EP95401746 A EP 95401746A EP 0697293 A1 EP0697293 A1 EP 0697293A1
Authority
EP
European Patent Office
Prior art keywords
microcapsules
pressure
microcapsule according
transesterification
vegetable oil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP95401746A
Other languages
German (de)
French (fr)
Other versions
EP0697293B1 (en
Inventor
Gérard Habar
Alain Le Pape
Catherine Descusse
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
COPIGRAPH
Original Assignee
COPIGRAPH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by COPIGRAPH filed Critical COPIGRAPH
Publication of EP0697293A1 publication Critical patent/EP0697293A1/en
Application granted granted Critical
Publication of EP0697293B1 publication Critical patent/EP0697293B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B41PRINTING; LINING MACHINES; TYPEWRITERS; STAMPS
    • B41MPRINTING, DUPLICATING, MARKING, OR COPYING PROCESSES; COLOUR PRINTING
    • B41M5/00Duplicating or marking methods; Sheet materials for use therein
    • B41M5/124Duplicating or marking methods; Sheet materials for use therein using pressure to make a masked colour visible, e.g. to make a coloured support visible, to create an opaque or transparent pattern, or to form colour by uniting colour-forming components
    • B41M5/165Duplicating or marking methods; Sheet materials for use therein using pressure to make a masked colour visible, e.g. to make a coloured support visible, to create an opaque or transparent pattern, or to form colour by uniting colour-forming components characterised by the use of microcapsules; Special solvents for incorporating the ingredients
    • B41M5/1655Solvents

Definitions

  • the present invention relates to microcapsules useful in particular for making carbonless pressure-sensitive paper, containing an organic solution of a hydrophobic dye, the solvent of which is at least partly of vegetable origin.
  • the invention also relates to pressure-sensitive paper coated on one side with a layer of such microcapsules and to the bundle of pressure-sensitive paper comprising at least one paper according to the invention.
  • the invention relates generally to CB, CFB and autonomous sheets.
  • the operating principle of carbonless pressure-sensitive paper consists in bursting the microcapsules under the pressure of a pen or under the shock caused by a typewriter strike or by the needles of a dot-matrix printer or more generally by all the so-called "impact" printing processes.
  • the internal phase contained in the microcapsules thus released flows on the CF receiving layer and the chromogenic agents react with the developer to form the colored image.
  • solvents are most often mixed with diluents such as kerosene, light mineral oils or alkylbenzenes (for example dodecylbenzene) etc.
  • solvents of natural origin such as vegetable oils (soya, rapeseed, olive, peanut, palm kernel, corn, sunflower, copra, sesame, castor, palm, babassu, jojoba, etc. ) in particular in American patents No. 2,712,507, 2,730,457, 3,016,308, 4,783,196, 4,923,641 and European patent applications No. 86,636, 155,593, 262,569.
  • microcapsules according to the invention make it possible to overcome the drawbacks mentioned above and are characterized in that the solvent for the hydrophobic chromogenic agent comprises an ester obtained by transesterification of a vegetable oil.
  • microcapsules advantageously, but not exclusively, those formed from a wall of crosslinked gelatin.
  • esters is generally meant the mixture obtained by transesterification, comprising at least 95% fatty acid esters of natural origin.
  • Transesterification is the chemical operation which consists in exchanging glycerol in an acidic or basic medium with a monoalcohol, generally with a short chain, which leads to the formation of an ester, then eliminating the glycerol.
  • the solvent must contain sufficient ester obtained by transesterification of a vegetable oil to meet the conditions set out above.
  • oils can be used alone or as a mixture.
  • the alcohol part of the ester resulting from the transesterification is a lower linear or branched alcohol residue, that is to say of which the carbon number ranges from C1 to C10.
  • the alcohol residue is a C en to C8 residue.
  • alcohol residues mention may be made of the residues of the following alcohols: methanol, ethanol, n-propanol, isopropanol, n-butanol, isobutanol, t-butanol, 2-ethylhexanol.
  • phthalic type derivatives such as 3,3-bis (4-dimethylaminophenyl) -6-dimethylamino-phthalide (CVL) and 3,3-bis (1-octyl- 2-methylindole-3-yl) phthalide or fluorane derivatives such as 2-anilino-3 methyl-6 dialkylamino -2 '- (N'-eryth-N-phenylamino-4'-methylfluorane) or 2'-anilino-3' methyl-6 diethylamino fluorane, 6'-dimethylamino-2 '- (N-ethyl-N-phenylamino-4'-methylfluorane), 3'-chloro-6'-cyclohexylaminofluorane or 3,7-bis (dimethylamino) -10-benzoylphenotiazine (BLMB ) and bisarylcarbazo
  • the solution of chromogenic agent in the solvent is around 5% by weight.
  • the solvent comprises at least 30% by weight of ester obtained by transesterification of a vegetable oil.
  • the solvent may contain mineral oils.
  • mineral oils which it is possible to use in combination with the esters, mention may be made, for example, of kerosene, paraffinic or naphthenic oil.
  • Preferably light naphthenic or paraffinic oils are used.
  • the alcohol part of these esters is most of the time chosen from the alcohol residues already mentioned above for the esters obtained by transesterification of a vegetable oil.
  • mineral oils are preferred.
  • the invention also relates to a process for the preparation of such microcapsules.
  • an emulsion of a hydrophobic phase consisting of an organic solution as described previously of a chromogenic substance, in a basic aqueous phase comprising several colloids including gelatin and one or more other anionic colloids among which mention may be made of carboxymethylcellulose (CMC) and a maleic anhydride copolymer such as a copolymer of l 'ethyl ethervinyl and maleic anhydride (PVMMA) or a copolymer of ethylene and maleic anhydride (EMA).
  • CMC carboxymethylcellulose
  • PVMMA copolymer of l 'ethyl ethervinyl and maleic anhydride
  • EMA copolymer of ethylene and maleic anhydride
  • the temperature is then raised and the emulsion is coacerved by adding an appropriate acid, in particular acetic acid, in order to adjust the pH to around 4.
  • an appropriate acid in particular acetic acid
  • Liquid-walled microcapsules are thus formed by formation of the coacervate around the droplets of emulsified oil. Cooling the mixture to about 10 ° C causes the walls of liquid coacervate to solidify.
  • a curing agent such as formalin or glutaraldehyde is then added in order to crosslink said solid walls of coacervate and to obtain the desired microcapsules.
  • the emulsions obtained were more stable and had a narrower particle size distribution than the emulsions prepared with solvents based on virgin oil.
  • the emulsion obtained is of the oil in water type and comprises droplets of the hydrophobic phase whose diameter is between 1 and 12 micrometers (preferably 3 to 8 micrometers).
  • microcapsules obtained are mixed with starch binders or latexes, a spacer, generally calibrated wheat starch and various additives such as optical brightener, water retention etc.
  • the subject of the invention is also a pressure-sensitive paper coated on one side with a layer of microcapsules as described above.
  • This paper support constituting the transmitting sheet, called CB, with a grammage generally between 40 to 90 g / m 2 was coated by coating the suspension of microcapsules, then these microcapsules were dried to obtain the paper according to the invention.
  • the method of coating and the formulation of the coating bath are not critical to the invention.
  • the invention also relates to a bundle of pressure-sensitive paper comprising, as has been described in the preamble to the present description, a transmitting sheet and a receiving sheet, and optionally one or more intermediate sheets (CFB) and also so-called autonomous sheets obtained by coating the front of a mixture of microcapsules and receiving layers.
  • a bundle of pressure-sensitive paper comprising, as has been described in the preamble to the present description, a transmitting sheet and a receiving sheet, and optionally one or more intermediate sheets (CFB) and also so-called autonomous sheets obtained by coating the front of a mixture of microcapsules and receiving layers.
  • CFRB intermediate sheets
  • the CF receiving paper associated with the CB sheet is preferably of the "activated clay" type as described in French patents 2,581,350 or US 4,422,670, but it is also possible to use a phenolic type CF such as those described in US Patents 4,559,242 or 4,769,305, or a CF of the zinc salycilate type.
  • the use of the solvent according to the invention makes it possible to improve, in addition to the viscosity and the quality of the emulsion, the degree of encapsulation in a completely surprising manner but also the intensity and the light fastness of the 'writing.
  • the organic phase and the aqueous phase are mixed with stirring and emulsified using an Ultra-TURRAX type apparatus until particles having an average diameter between 5 and 6 ⁇ m are obtained (the diameter is measured using a Coulter LS 100 laser granulometer).
  • Carboxymethylcellulose has a degree of substitution of the order of 0.8 and a viscosity in 3% aqueous solution at 20 ° C of between 60 and 100 mPas measured using a Haake VT 181 viscometer with MVI coaxial cylinders at 180 rpm.
  • the temperature is raised to 60 ° C and acetic acid is added over 30 minutes to adjust the pH to 4.3.
  • the coacervate is cooled to 8 ° C. and this temperature is maintained for 10 hours.
  • Example 1 is reproduced by replacing the rapeseed methyl ester obtained by transesterification produced by Novamont with the same type of product produced by the company Robbe under the brand Estorob or Lubrirob 926.
  • Example 2 is repeated but with the methyl ester of rapeseed produced by the company Henkel.
  • Example 1 is reproduced by replacing the rapeseed methyl ester with an isopropyl soy ester obtained by transesterification manufactured by the company Stéarinerie Dubois et Fils.
  • Example 4 is reproduced by replacing the soybean oil with a "tall oil” (product manufactured by the company Stéarinerie Dubois et Fils) from wood.
  • Example 1 is repeated, replacing the solvent mixture with 400 g of Novamont rapeseed methyl ester + 445 g of purified isopropyl palmitate (Kessco IPP brand from Akzo).
  • Example 1 is repeated, replacing the solvent mixture with 400 g of Novamont rapeseed methyl ester + 445 g of purified methyl stearate (brand Edenol W750 from Henkel).
  • Example 1 is reproduced by replacing the rapeseed methyl ester with refined virgin rapeseed oil (produced by the company CEREOL).
  • the loss of reactivity of the CB is measured by crushing with the calender before and after aging.
  • the loss of whiteness of the CF due to the migration of part of the chromogenic agents present in the microcapsules is measured compared to a blank test on the same CF.

Landscapes

  • Color Printing (AREA)
  • Manufacturing Of Micro-Capsules (AREA)

Abstract

Microcapsule useful for pressure sensitive copying paper contains an organic soln. of a hydrophobic chromogen. The microcapsule is characterised in that the solvent is a mixt. obtd. by transesterification of a vegetable oil. Also claimed is the pressure sensitive paper coated on one side with the microcapsule.

Description

La présente invention concerne des microcapsules utiles notamment pour la réalisation de papier autocopiant sensible à la pression, contenant une solution organique d'un colorant hydrophobe dont le solvant est au moins en partie d'origine végétale.The present invention relates to microcapsules useful in particular for making carbonless pressure-sensitive paper, containing an organic solution of a hydrophobic dye, the solvent of which is at least partly of vegetable origin.

L'invention concerne également le papier sensible à la pression revêtu sur une face d'une couche de telles microcapsules et la liasse de papier sensible à la pression comportant au moins un papier selon l'invention.The invention also relates to pressure-sensitive paper coated on one side with a layer of such microcapsules and to the bundle of pressure-sensitive paper comprising at least one paper according to the invention.

Une liasse de papier autocopiant sensible à la pression comprend :

  • une feuille émettrice appelée CB, obtenue par enduction au verso de microcapsules contenant une solution d'agents chromogènes hydrophobes,
  • une feuille réceptrice appelée CF, obtenue par enduction au recto d'une couche absorbante et réactive vis-à-vis des agents chromogènes,
  • une ou plusieurs feuilles intermédiaires comprenant à la fois les microcapsules au verso et la couche réceptrice au recto que l'on appelle CFB.
A bundle of carbonless pressure sensitive paper includes:
  • an emitting sheet called CB, obtained by coating on the back of microcapsules containing a solution of hydrophobic chromogenic agents,
  • a receiving sheet called CF, obtained by coating the front with an absorbent and reactive layer vis-à-vis chromogenic agents,
  • one or more intermediate sheets comprising both the microcapsules on the back and the receiving layer on the front called CFB.

Il existe aussi des feuilles, dites "autonomes", obtenues par enduction au recto d'un mélange de microcapsules et de couche réceptrice.There are also sheets, called "autonomous", obtained by coating the front of a mixture of microcapsules and receiving layer.

L'invention concerne de façon générale les feuillets CB, CFB et autonomes. Le principe de fonctionnement de papier autocopiant sensible à la pression consiste à faire éclater les microcapsules sous la pression d'un stylo ou sous le choc causé par une frappe de machine à écrire ou par les aiguilles d'une imprimante matricielle ou plus généralement par tous les procédés d'impression dits à "impacts". La phase interne contenue dans les microcapsules ainsi libérée s'écoule sur la couche réceptrice CF et les agents chromogènes réagissent avec le révélateur pour former l'image colorée.The invention relates generally to CB, CFB and autonomous sheets. The operating principle of carbonless pressure-sensitive paper consists in bursting the microcapsules under the pressure of a pen or under the shock caused by a typewriter strike or by the needles of a dot-matrix printer or more generally by all the so-called "impact" printing processes. The internal phase contained in the microcapsules thus released flows on the CF receiving layer and the chromogenic agents react with the developer to form the colored image.

Le solvant utilisé pour préparer la phasé interne joue un rôle primordial sur la qualité finale du produit. Il doit satisfaire aux exigences suivantes :

  • . être incolore et inodore,
  • . présenter un bon pouvoir solvant vis-à-vis des agents chromogènes,
  • . être inerte chimiquement vis-à-vis des agents chromogènes et vis-à-vis des matériaux utilisés pour former les parois des microcapsules,
  • . avoir un point d'ébullition élevé et une très faible tension de vapeur à température ambiante,
  • . être liquide à la température d'utilisation du papier autocopiant (jusqu'à -10°C voir - 20°C en hiver),
  • . présenter la viscosité la plus faible possible afin de faciliter l'écoulement de la phase interne lors de la rupture des capsules,
  • . avoir une bonne stabilité à la chaleur et à la lumière,
  • . permettre un développement rapide et intense des agents chromogènes sur le réactif du feuillet CF,
  • . donner une bonne solidité à la lumière de l'image obtenue sur le feuillet CF,
  • . être pratiquement insoluble dans l'eau pour pouvoir être encapsulé,
    • être sans danger pour le corps humain et pour l'environnement,
    • présenter une biodégradabilité élevée,
    • avoir un prix faible compatible avec les prix actuels du papier autocopiant chimique.
The solvent used to prepare the internal phase plays a key role in the final quality of the product. It must meet the following requirements:
  • . be colorless and odorless,
  • . have good solvent power with regard to chromogenic agents,
  • . be chemically inert vis-à-vis the chromogenic agents and vis-à-vis the materials used to form the walls of the microcapsules,
  • . have a high boiling point and a very low vapor pressure at room temperature,
  • . be liquid at the temperature of use of carbonless paper (down to -10 ° C see - 20 ° C in winter),
  • . have the lowest possible viscosity in order to facilitate the flow of the internal phase during the rupture of the capsules,
  • . have good heat and light stability,
  • . allow rapid and intense development of chromogenic agents on the reagent of the CF sheet,
  • . give good light fastness to the image obtained on the CF sheet,
  • . be practically insoluble in water so that it can be encapsulated,
    • be safe for the human body and the environment,
    • exhibit high biodegradability,
    • have a low price compatible with current prices for carbonless carbon paper.

Actuellement, parmi les solvants utilisés couramment, on peut citer les terphényles hydrogénés, les alkylnaphtalènes, les alkylbiphényles, les dérivés de diarylméthane, les dérivés de dibenzylbenzène, les paraffines chlorées, etc.Currently, among the solvents commonly used, mention may be made of hydrogenated terphenyls, alkylnaphthalenes, alkylbiphenyls, diarylmethane derivatives, dibenzylbenzene derivatives, chlorinated paraffins, etc.

Ces solvants sont le plus souvent mélangés à des diluants tels que les kérosènes, les huiles minérales légères ou les alkylbenzènes (par exemple dodécylbenzène) etc.These solvents are most often mixed with diluents such as kerosene, light mineral oils or alkylbenzenes (for example dodecylbenzene) etc.

Tous ces produits satisfont assez bien à toutes les exigences énoncées ci-dessus sauf les dernières concernant la biodégradabilité et la non toxicité vis-à-vis de l'environnement d'où un risque de pollution lors de l'utilisation et la destruction des papiers autocopiants chimiques.All these products fairly well meet all the requirements set out above except the last concerning biodegradability and non-toxicity vis-à-vis the environment hence a risk of pollution during the use and destruction of paper chemical carbonless.

Pour pallier ces défauts, on a envisagé d'utiliser les solvants d'origine naturelle tels que les huiles végétales (soja, colza, olive, arachide, palmiste, maïs, tournesol, coprah, sésame, ricin, palme, babassu, jojoba etc.) notamment dans les brevets américains n° 2 712 507, 2 730 457, 3 016 308, 4 783 196, 4 923 641 et les demandes de brevets européens n° 86 636, 155 593, 262 569.To overcome these shortcomings, consideration has been given to using solvents of natural origin such as vegetable oils (soya, rapeseed, olive, peanut, palm kernel, corn, sunflower, copra, sesame, castor, palm, babassu, jojoba, etc. ) in particular in American patents No. 2,712,507, 2,730,457, 3,016,308, 4,783,196, 4,923,641 and European patent applications No. 86,636, 155,593, 262,569.

Aucune de ces huiles végétales ne donne des résultats satisfaisants, car dans tous les cas on observe :

  • 1) une émulsification, de la phase interne dans l'eau, très difficile avec en final une courbe granulométrique très étalée (présence de particules fines ≦ 1 µm et de particules grossières de diamètre supérieur à 8 µm).
    Ce défaut se traduit en pratique par une perte de rendement en duplication liée aux petites capsules et un papier trop sensible au stockage en pile et aux différentes manipulations à cause des grosses capsules (bleuissement ou noircissement prématuré du papier avant utilisation) et en particulier lors du passage sur les machines d'impression,
  • 2) une viscosité trop élevée (mauvais écoulement de la phase interne d'où une perte de rendement),
  • 3) une révélation insuffisante des agents chromogènes en présence d'huile végétale (duplication d'intensité faible), notamment pour les dérivés de fluorane ou de phtalide.
  • 4) des tenues au vieillissement insuffisantes des papiers CB, CFB et autonomes en particulier en atmosphère humide et chaude (coloration bleue ou noire des papiers avant utilisation),
  • 5) une tenue insuffisante à la lumière de l'image colorée sur CF,
  • 6) une biodégradabilité souvent insuffisante.
None of these vegetable oils gives satisfactory results, because in all cases we observe:
  • 1) an emulsification, of the internal phase in water, very difficult with in the end a very spread particle size curve (presence of fine particles ≦ 1 μm and coarse particles of diameter greater than 8 μm).
    This defect is reflected in practice by a loss of duplication yield linked to small capsules and a paper that is too sensitive to stack storage and to various manipulations because of large capsules (premature blueing or blackening of the paper before use) and in particular during passage on printing machines,
  • 2) too high a viscosity (poor flow of the internal phase resulting in a loss of yield),
  • 3) insufficient revelation of the chromogenic agents in the presence of vegetable oil (low intensity duplication), in particular for fluorane or phthalide derivatives.
  • 4) insufficient aging resistance of CB, CFB and autonomous papers in particular in a humid and hot atmosphere (blue or black coloring of the papers before use),
  • 5) insufficient resistance to light in the colored image on CF,
  • 6) often insufficient biodegradability.

Différentes améliorations ont été proposées pour essayer d'utiliser les huiles végétales en minimisant leurs inconvénients, en particulier le brevet européen n' 520 639 préconise des mélanges d'huiles végétales avec des mono- ou di- esters d'acides gras. Cette solution s'avère insuffisante pour les points 1), 2) et 3) et apporte peu d'amélioration sur les points 4) et 5).Various improvements have been proposed to try to use vegetable oils while minimizing their drawbacks, in particular European patent n ° 520 639 recommends mixtures of vegetable oils with mono- or di-esters of fatty acids. This solution is insufficient for points 1), 2) and 3) and brings little improvement on points 4) and 5).

On a également proposé dans le brevet EP 593 192 d'utiliser un mono-, di- ou tri-ester fonctionnel saturé ou insaturé comme solvant. Cette réalisation est d'un coût très élevé sur le plan industriel.It has also been proposed in patent EP 593 192 to use a functional saturated or unsaturated mono-, di- or tri-ester as solvent. This achievement is of a very high cost on the industrial level.

Les microcapsules selon l'invention permettent de pallier les inconvénients cités plus haut et sont caractérisées en ce que le solvant de l'agent chromogène hydrophobe comprend un ester obtenu par transestérification d'une huile végétale.The microcapsules according to the invention make it possible to overcome the drawbacks mentioned above and are characterized in that the solvent for the hydrophobic chromogenic agent comprises an ester obtained by transesterification of a vegetable oil.

Parmi les microcapsules, on citera avantageusement, mais non exclusivement, celles formées d'une paroi de gélatine réticulée.Among the microcapsules, advantageously, but not exclusively, those formed from a wall of crosslinked gelatin.

Par "ester", on entend de façon générale le mélange obtenu par transestérification, comprenant au minimum 95 % d'esters d'acides gras d'origine naturelle.By "ester" is generally meant the mixture obtained by transesterification, comprising at least 95% fatty acid esters of natural origin.

La transestérification est l'opération chimique qui consiste à échanger en milieu acide ou basique le glycérol par un monoalcool, en général à chaîne courte, ce qui conduit à la formation d'ester, puis à éliminer le glycérol.Transesterification is the chemical operation which consists in exchanging glycerol in an acidic or basic medium with a monoalcohol, generally with a short chain, which leads to the formation of an ester, then eliminating the glycerol.

On a trouvé que cette transformation chimique des huiles végétales, bien que n'éliminant pas les impuretés présentes dans les huiles d'origine, et ne modifiant en rien la composition en acides gras de ces mêmes huiles, permettait d'atteindre les niveaux de performances des esters synthétiques tels que décrits dans le brevet EP 593 192.It has been found that this chemical transformation of vegetable oils, although not eliminating the impurities present in the original oils, and in no way modifying the fatty acid composition of these same oils, makes it possible to achieve performance levels. synthetic esters as described in patent EP 593,192.

Ceci est d'autant plus intéressant que le coût de fabrication d'un tel produit est très inférieur à celui des esters synthétiques.This is all the more interesting since the manufacturing cost of such a product is much lower than that of synthetic esters.

Ceci est particulièrement vrai pour les mélanges appelés communément "diester", développés pour être utilisés comme carburants, et donc disponibles en grande quantité à un prix concurrentiel.This is particularly true for the mixtures commonly called "diester", developed to be used as fuels, and therefore available in large quantities at a competitive price.

On a trouvé que cette transformation chimique des huiles végétales permettait d'obtenir à un coût industriel acceptable des microsphères et subséquemment des papiers autocopiants sensibles à la pression présentant des propriétés nettement améliorées par rapport à ceux comportant des microcapsules telles que décrites dans l'art antérieur.It has been found that this chemical transformation of vegetable oils made it possible to obtain microspheres and subsequently carbonless pressure-sensitive papers having appreciably improved properties compared to those comprising microcapsules as described in the prior art at an acceptable industrial cost. .

Le solvant doit contenir suffisamment d'ester obtenu par transestérification d'une huile végétale pour satisfaire aux conditions énoncées ci-dessus.The solvent must contain sufficient ester obtained by transesterification of a vegetable oil to meet the conditions set out above.

Parmi les huiles végétales de départ convenant dans le cas de la présente invention, on peut citer à titre indicatif et non limitatif, les huiles de palmiste, de colza, de soja, de lin, de coprah, de palme, de maïs, tournesol, olive et arachide. Il est également possible d'utiliser les triglycérides appelés du terme anglo-saxon "tall-oil"comportant une forte proportion de trioléate de glycérol.Among the starting vegetable oils which are suitable in the case of the present invention, there may be mentioned by way of nonlimiting indication, palm kernel, rapeseed, soybean, flax, copra, palm, corn, sunflower oils, olive and peanut. It is also possible to use the triglycerides called from the English term "tall oil" comprising a high proportion of glycerol trioleate.

Bien entendu, les huiles précitées peuvent être utilisées seules ou en mélange.Of course, the abovementioned oils can be used alone or as a mixture.

Comme indiqué précédemment, il est souhaitable que la partie alcool de l'ester résultant de la transestérification soit un reste alcool linéaire ou ramifié inférieur, c'est-à-dire dont le nombre de carbone va de C₁ à C₁₀.As indicated above, it is desirable for the alcohol part of the ester resulting from the transesterification to be a lower linear or branched alcohol residue, that is to say of which the carbon number ranges from C₁ to C₁₀.

De préférence, le reste alcool est un reste en C₁ à C₈.Preferably, the alcohol residue is a C en to C₈ residue.

Parmi les restes alcools, on peut citer les restes des alcools suivants: méthanol, éthanol, n-propanol, isopropanol, n-butanol, isobutanol, t-butanol, 2-éthylhexanol.Among the alcohol residues, mention may be made of the residues of the following alcohols: methanol, ethanol, n-propanol, isopropanol, n-butanol, isobutanol, t-butanol, 2-ethylhexanol.

Parmi les agents chromogènes utilisés, on peut citer à titre indicatif les dérivés du type phtalique comme le 3,3-bis(4-diméthylaminophényl)-6-diméthylamino-phtalide (CVL) et le 3,3-bis(1-octyl-2-méthylindole-3-yle)phtalide ou des dérivés de fluorane comme les 2-anilino-3 méthyl-6 dialkylamino -2'-(N'-érhyl-N-phénylamino-4'-méthylfluorane) ou le 2'-anilino-3' méthyl-6 diéthylamino fluorane, le 6'-diméthylamino-2'-(N-éthyl-N-phénylamino-4'-méthylfluorane), le 3'-chloro-6'-cyclohexylaminofluorane ou le 3,7-bis(diméthylamino)-10-benzoylphenotiazine (BLMB) et les composés de bisarylcarbazolylméthane. Cette liste étant non limitative et pouvant être étendue à toutes les substances chromogènes couramment utilisées dans l'art considéré.Mention may be made, among the chromogenic agents used, of phthalic type derivatives such as 3,3-bis (4-dimethylaminophenyl) -6-dimethylamino-phthalide (CVL) and 3,3-bis (1-octyl- 2-methylindole-3-yl) phthalide or fluorane derivatives such as 2-anilino-3 methyl-6 dialkylamino -2 '- (N'-eryth-N-phenylamino-4'-methylfluorane) or 2'-anilino-3' methyl-6 diethylamino fluorane, 6'-dimethylamino-2 '- (N-ethyl-N-phenylamino-4'-methylfluorane), 3'-chloro-6'-cyclohexylaminofluorane or 3,7-bis (dimethylamino) -10-benzoylphenotiazine (BLMB ) and bisarylcarbazolylmethane compounds. This list is non-limiting and can be extended to all the chromogenic substances commonly used in the art considered.

La solution d'agent chromogène dans le solvant est aux environs de 5 % en poids.The solution of chromogenic agent in the solvent is around 5% by weight.

Selon une variante préférée, le solvant comprend au moins 30 % en poids d'ester obtenu par transestérification d'une huile végétale.According to a preferred variant, the solvent comprises at least 30% by weight of ester obtained by transesterification of a vegetable oil.

Outre lesdits esters, le solvant peut contenir des huiles minérales.In addition to said esters, the solvent may contain mineral oils.

Parmi les huiles minérales qu'il est possible d'utiliser en combinaison avec les esters, on peut citer à titre indicatif les kérosènes, les huiles paraffiniques ou naphténiques.Among the mineral oils which it is possible to use in combination with the esters, mention may be made, for example, of kerosene, paraffinic or naphthenic oil.

On utilisera de préférence les huiles naphténiques ou paraffiniques légères.Preferably light naphthenic or paraffinic oils are used.

La partie alcool de ces esters est la plupart du temps choisie parmi les restes alcool déjà précités pour les esters obtenus par transestérification d'une huile végétale.The alcohol part of these esters is most of the time chosen from the alcohol residues already mentioned above for the esters obtained by transesterification of a vegetable oil.

Selon une réalisation préférée, la microcapsule est caractérisée en ce que le solvant comprend en pourcentage en poids :

  • mélange obtenu par transestérification d'une huile végétale   30 à 100 %
  • huile minérale   0 à 70 %
According to a preferred embodiment, the microcapsule is characterized in that the solvent comprises in percentage by weight:
  • mixture obtained by transesterification of a vegetable oil 30 to 100%
  • mineral oil 0 to 70%

De préférence encore, le solvant comprend en pourcentage en poids :

  • mélange obtenu par transestérification d'une huile végétale   30 à 50%
  • huile minérale   50 à 70%.
More preferably, the solvent comprises in percentage by weight:
  • mixture obtained by transesterification of a vegetable oil 30 to 50%
  • mineral oil 50 to 70%.

Selon un mode de réalisation avantageux, on préfèrera les huiles minérales.According to an advantageous embodiment, mineral oils are preferred.

L'invention est également relative à un procédé de préparation de telles microcapsules.The invention also relates to a process for the preparation of such microcapsules.

Selon un procédé général, on forme une émulsion d'une phase hydrophobe constituée d'une solution organique telle que décrite précédemment d'une substance chromogène, dans une phase aqueuse basique comportant plusieurs colloïdes dont la gélatine et un ou plusieurs autres colloïdes anioniques parmi lesquels on peut citer la carboxyméthylcellulose (CMC) et un copolymère de l'anhydride maléïque tel qu'un copolymère de l'éthervinylméthylique et de l'anhydride maléïque (PVMMA) ou un copolymère de l'éthylène et de l'anhydride maléïque (EMA).According to a general method, an emulsion of a hydrophobic phase is formed consisting of an organic solution as described previously of a chromogenic substance, in a basic aqueous phase comprising several colloids including gelatin and one or more other anionic colloids among which mention may be made of carboxymethylcellulose (CMC) and a maleic anhydride copolymer such as a copolymer of l 'ethyl ethervinyl and maleic anhydride (PVMMA) or a copolymer of ethylene and maleic anhydride (EMA).

On élève ensuite la température et l'on procède à la coacervation de l'émulsion par ajout d'un acide approprié notamment l'acide acétique afin de régler le pH aux environs de 4. Des microcapsules à paroi liquide se constituent ainsi par formation du coacervat autour des gouttelettes d'huile émulsionnée. Le refroidissement du mélange jusqu'à environ 10°C provoque la solidification des parois de coacervat liquide.The temperature is then raised and the emulsion is coacerved by adding an appropriate acid, in particular acetic acid, in order to adjust the pH to around 4. Liquid-walled microcapsules are thus formed by formation of the coacervate around the droplets of emulsified oil. Cooling the mixture to about 10 ° C causes the walls of liquid coacervate to solidify.

On ajoute ensuite un agent de durcissement comme le formol ou le glutaraldéhyde afin de réticuler lesdites parois solides de coacervat et obtenir les microcapsules souhaitées.A curing agent such as formalin or glutaraldehyde is then added in order to crosslink said solid walls of coacervate and to obtain the desired microcapsules.

Il est ensuite possible d'ajouter des liants et d'autres ingrédients classiques adaptés à la suspension de microcapsules pour obtenir une composition de revêtement pour papier sensible à la pression.It is then possible to add binders and other conventional ingredients suitable for the suspension of microcapsules to obtain a coating composition for pressure-sensitive paper.

Selon un procédé particulier décrit dans la demande FR 94 03 838 déposée le 31 Mars 1994 dont le contenu est incorporé par référence, on effectue les étapes suivantes :

  • formation d'une suspension dans une phase aqueuse acide de particules constituées de gouttelettes de la solution organique décrite précédemment, lesdites gouttelettes étant revêtues d'un coacervat formé de gélatine, d'un premier colloïde anionique constitué par l'acide polyacrylique et d'un second colloïde anionique constitué par de la carboxyméthylcellulose, et lesdites particules ayant un diamètre de 1 à 12 µm environ, de préférence de 3 à 8 µm.
  • refroidissement pour solidifier la paroi,
  • réticulation de la gélatine pour fixer la structure et rendre le processus irréversible,
  • réchauffement et neutralisation.
According to a particular process described in application FR 94 03 838 filed on March 31, 1994, the content of which is incorporated by reference, the following steps are carried out:
  • formation of a suspension in an acidic aqueous phase of particles consisting of droplets of the organic solution described above, said droplets being coated with a coacervate formed of gelatin, a first anionic colloid consisting of polyacrylic acid and a second anionic colloid consisting of carboxymethylcellulose, and said particles having a diameter of from 1 to 12 μm approximately, preferably from 3 to 8 μm.
  • cooling to solidify the wall,
  • crosslinking of gelatin to fix the structure and make the process irreversible,
  • warming and neutralization.

On a noté qu'avec les solutions organiques d'agents chromogènes selon l'invention, les émulsions obtenues étaient plus stables et présentaient une courbe granulométrique plus resserrée que les émulsions préparées avec des solvants à base d'huile vierge.It was noted that with the organic solutions of chromogenic agents according to the invention, the emulsions obtained were more stable and had a narrower particle size distribution than the emulsions prepared with solvents based on virgin oil.

L'émulsion obtenue est du type huile dans l'eau et comporte des gouttelettes de la phase hydrophobe dont le diamètre est compris entre 1 et 12 micromètres (de préférence 3 à 8 micromètres).The emulsion obtained is of the oil in water type and comprises droplets of the hydrophobic phase whose diameter is between 1 and 12 micrometers (preferably 3 to 8 micrometers).

Bien entendu, d'autres procédés peuvent également être utilisés sans sortir du cadre de la présente invention.Of course, other methods can also be used without departing from the scope of the present invention.

Parmi ces autres procédés on peut citer :

  • Un procédé à base de gélatine par coacervation complexe tel que celui décrit dans l'exemple 1 ou dans les brevets US 4 402 856, FR 2 458 313, EP 339866,
  • un procédé à base de résines mélamine-formol comme ceux décrits dans les brevets US 4 406 816, 4 444 699, 4 898 696, ou EP 319 337 et 444559,
  • un procédé à base de polyurées ou polyuréthanes comme ceux décrits dans les brevets FR 2 591 124 ou US 4 668 580, 4 785 048, 4 898 780 et 5 075 279,
  • ou tout autre procédé d'encapsulation connu pour la fabrication de microcapsules servant à la fabrication du papier autocopiant chimique.
Among these other processes, there may be mentioned:
  • A method based on gelatin by complex coacervation such as that described in Example 1 or in US Patents 4,402,856, FR 2,458,313, EP 339866,
  • a process based on melamine-formaldehyde resins such as those described in US Patents 4,406,816, 4,444,699, 4,898,696, or EP 319,337 and 444,559,
  • a process based on polyureas or polyurethanes such as those described in patents FR 2 591 124 or US 4 668 580, 4 785 048, 4 898 780 and 5 075 279,
  • or any other known encapsulation process for the manufacture of microcapsules used for the manufacture of chemical carbonless paper.

Les microcapsules obtenues sont mélangées avec des liants amylacés ou des latex, un distanceur, généralement de l'amidon de blé calibré et divers additifs tels que azurant optique, rétenteur d'eau etc.The microcapsules obtained are mixed with starch binders or latexes, a spacer, generally calibrated wheat starch and various additives such as optical brightener, water retention etc.

Elles sont ensuite couchées sur un support papier.They are then laid down on a paper support.

L'invention a également pour objet un papier sensible à la pression revêtu sur une face d'une couche de microcapsules telles qu'elles ont été décrites précédemment.The subject of the invention is also a pressure-sensitive paper coated on one side with a layer of microcapsules as described above.

Ce support papier constituant la feuille émettrice, appelée CB, d'un grammage généralement compris entre 40 à 90 g/m a été revêtu par couchage de la suspension de microcapsules, puis ces microcapsules ont été séchées pour obtenir le papier selon l'invention.This paper support constituting the transmitting sheet, called CB, with a grammage generally between 40 to 90 g / m 2 was coated by coating the suspension of microcapsules, then these microcapsules were dried to obtain the paper according to the invention.

Le mode d'enduction ainsi que la formulation du bain de couchage ne sont pas critiques pour l'invention.The method of coating and the formulation of the coating bath are not critical to the invention.

L'invention a également pour objet une, liasse de papier sensible à la pression comportant comme cela a été décrit dans le préambule de la présente description une feuille émettrice et une feuille réceptrice, et éventuellement une ou plusieurs feuilles intermédiaires (CFB) et également des feuilles dites autonomes obtenues par enduction au recto d'un mélange de microcapsules et de couches réceptrices.The invention also relates to a bundle of pressure-sensitive paper comprising, as has been described in the preamble to the present description, a transmitting sheet and a receiving sheet, and optionally one or more intermediate sheets (CFB) and also so-called autonomous sheets obtained by coating the front of a mixture of microcapsules and receiving layers.

Le papier récepteur CF associé à la feuille CB est de préférence du type "argile activé" tel que décrit dans les brevets français 2 581 350 ou US 4 422 670, mais on peut aussi utiliser un CF de type phénolique tel que ceux décrits dans les brevets US 4 559 242 ou 4 769 305, ou un CF du type salycilate de zinc.The CF receiving paper associated with the CB sheet is preferably of the "activated clay" type as described in French patents 2,581,350 or US 4,422,670, but it is also possible to use a phenolic type CF such as those described in US Patents 4,559,242 or 4,769,305, or a CF of the zinc salycilate type.

L'utilisation du solvant selon l'invention permet d'améliorer outre la viscosité et la qualité de l'émulsion, le taux d'encapsulation d'une manière tout à fait surprenante mais aussi l'intensité et la tenue à la lumière de l'écriture.The use of the solvent according to the invention makes it possible to improve, in addition to the viscosity and the quality of the emulsion, the degree of encapsulation in a completely surprising manner but also the intensity and the light fastness of the 'writing.

Par ailleurs les tests de vieillissement accéléré des feuillets CB, soit en chaleur sèche, soit en chaleur humide sont améliorés.In addition, the accelerated aging tests of the CB sheets, either in dry heat or in wet heat are improved.

L'invention est illustrée par les exemples suivants :The invention is illustrated by the following examples:

Exemple 1Example 1

Dans 1,2 l d'eau désionisée à 40°C, on introduit sous agitation 55 g de gélatine d'une valeur bloom d'environ 160. On chauffe entre 40 et 50 C jusqu'à dissolution totale de la gélatine puis on ajoute 18 g d'une solution à 50 % de polyacrylate de sodium (de masse molaire ≅ 1800) en goutte de soude.In 1.2 l of deionized water at 40 ° C., 55 g of gelatin with a bloom value of about 160 are introduced with stirring. The mixture is heated between 40 and 50 C until the gelatin is completely dissolved and then added 18 g of a 50% solution of sodium polyacrylate (molar mass ≅ 1800) in a drop of soda.

En parallèle, on prépare une phase organique hydrophobe, par chauffage entre 100 et 130°C pendant une heure, du mélange suivant :

  • 500 g d'ester méthylique de colza fabriqué par la société Novamont (MATROL BI 141), obtenu par transestérification,
  • 345 g d'huile naphténique légère,
  • 21 g de noir ODB2
  • 9 g de noir S205 (Yamada)
  • 3,8 g de bleu CVL
  • 3,5 g de bleu Pergascript SRB (Ciba Geigy)
  • 4,2 g d'orange Pergascript I5R (Ciba Geigy).
In parallel, a hydrophobic organic phase is prepared, by heating between 100 and 130 ° C for one hour, of the following mixture:
  • 500 g of rapeseed methyl ester manufactured by the company Novamont (MATROL BI 141), obtained by transesterification,
  • 345 g of light naphthenic oil,
  • 21 g ODB2 black
  • 9 g of black S205 (Yamada)
  • 3.8 g CVL blue
  • 3.5 g blue Pergascript SRB (Ciba Geigy)
  • 4.2 g of orange Pergascript I5R (Ciba Geigy).

On mélange la phase organique et la phase aqueuse sous agitation et on émulsionne à l'aide d'un appareil du type Ultra-TURRAX jusqu'à obtention de particules ayant un diamètre moyen compris entre 5 et 6 µm (la mesure du diamètre est réalisée à l'aide d'un granulomètre à laser Coulter LS 100).The organic phase and the aqueous phase are mixed with stirring and emulsified using an Ultra-TURRAX type apparatus until particles having an average diameter between 5 and 6 μm are obtained (the diameter is measured using a Coulter LS 100 laser granulometer).

Ensuite on mélange dans un réacteur thermostatique, muni d'un agitateur, l'émulsion obtenue précédemment et une solution de 17 g de carboxyméthylcellulose dans 625 ml d'eau désionisée. La carboxyméthylcellulose a un degré de substitution de l'ordre de 0,8 et une viscosité en solution aqueuse à 3 % à 20°C comprise entre 60 et 100 mPas mesurée à l'aide d'un viscosimètre Haake VT 181 à cylindres coaxiaux MVI à 180 t/min.Then the emulsion obtained above and a solution of 17 g of carboxymethylcellulose in 625 ml of deionized water are mixed in a thermostatic reactor, equipped with a stirrer. Carboxymethylcellulose has a degree of substitution of the order of 0.8 and a viscosity in 3% aqueous solution at 20 ° C of between 60 and 100 mPas measured using a Haake VT 181 viscometer with MVI coaxial cylinders at 180 rpm.

On élève la température à 60°C et on ajoute de l'acide acétique en 30 minutes pour ajuster le pH à 4,3.The temperature is raised to 60 ° C and acetic acid is added over 30 minutes to adjust the pH to 4.3.

On refroidit le coacervat à 8°C et on maintient cette température pendant 10 heures.The coacervate is cooled to 8 ° C. and this temperature is maintained for 10 hours.

Le durcissement des parois est effectué en deux étapes :

  • 1ère étape : addition de 17 g de glutaraldéhyde à 50 % sous forte agitation,
  • 2ème étape : addition 4 heures plus tard de 66 g d'une solution à 26 % d'alun de chrome. On maintient la température à 8°C pendant 16 heures ainsi qu'une bonne agitation avant de remonter le pH à 7 à la température de 20°C.
The hardening of the walls is carried out in two stages:
  • 1st stage : addition of 17 g of 50% glutaraldehyde with vigorous stirring,
  • 2nd stage : addition 4 hours later of 66 g of a 26% solution of chromium alum. The temperature is maintained at 8 ° C for 16 hours and good agitation before raising the pH to 7 at the temperature of 20 ° C.

Exemple 2Example 2

On reproduit l'exemple 1 en remplaçant l'ester méthylique de colza obtenu par transestérification fabriqué par Novamont par le même type de produit fabriqué par la société Robbe sous la marque Estorob ou Lubrirob 926.Example 1 is reproduced by replacing the rapeseed methyl ester obtained by transesterification produced by Novamont with the same type of product produced by the company Robbe under the brand Estorob or Lubrirob 926.

Exemple 3Example 3

On reproduit l'exemple 2 mais avec l'ester méthylique du colza fabriqué par la société Henkel.Example 2 is repeated but with the methyl ester of rapeseed produced by the company Henkel.

Exemple 4Example 4

On reproduit l'exemple 1 en remplaçant l'ester méthylique de colza par un ester isopropylique de soja obtenu par transestérifiction fabriqué par la société Stéarinerie Dubois et Fils.Example 1 is reproduced by replacing the rapeseed methyl ester with an isopropyl soy ester obtained by transesterification manufactured by the company Stéarinerie Dubois et Fils.

Exemple 5Example 5

On reproduit l'exemple 4 en remplacant l'huile de soja par un "tall oil" (produit fabriqué par la société Stéarinerie Dubois et Fils) issu du bois.Example 4 is reproduced by replacing the soybean oil with a "tall oil" (product manufactured by the company Stéarinerie Dubois et Fils) from wood.

Exemple 6Example 6

On reproduit l'exemple 1 en remplaçant le mélange solvant par 400 g d'ester méthylique de colza de Novamont + 445 g de palmitate d'isopropyle purifié (marque Kessco IPP de la société Akzo).Example 1 is repeated, replacing the solvent mixture with 400 g of Novamont rapeseed methyl ester + 445 g of purified isopropyl palmitate (Kessco IPP brand from Akzo).

Exemple 7Example 7

On reproduit l'exemple 1 en remplaçant le mélange solvant par 400 g d'ester méthylique de colza de Novamont + 445 g de stéarate de méthyle purifié (marque Edenol W750 de la société Henkel).Example 1 is repeated, replacing the solvent mixture with 400 g of Novamont rapeseed methyl ester + 445 g of purified methyl stearate (brand Edenol W750 from Henkel).

Exemple 8 (comparatif)Example 8 (comparative)

On reproduit l'exemple 1 en remplaçant l'ester méthylique de colza par de l'huile de colza vierge raffinée (produit par la société CEREOL).Example 1 is reproduced by replacing the rapeseed methyl ester with refined virgin rapeseed oil (produced by the company CEREOL).

RésultatsResults

Les contrôles effectués sur les microcapsules ainsi que sur les papiers CB obtenus par couchage de ces microcapsules sont réunis dans le tableau ci-après.

  • . Le contrôle de la granulométrie est effectué à l'aide d'un granulomètre à laser (Coulter LS 100). On détermine le diamètre moyen et la dispersion en taille caractérisée par la variance.
  • . La viscosité est mesurée à l'aide d'un viscosimètre HAAKE VT 181 avec mobile MV1,
  • . Le taux de matières sèches à l'aide d'un dessicateur à infrarouge (la phase interne est comptée comme matière sèche),
  • . Le taux d'encapsulation est mesuré par couchage des microcapsules sur un papier CF puis écrasement sous 500 bars de pression sur la moitié de la feuille. On mesure ensuite la différence de densité optique entre la partie écrasée et la partie non écrasée à l'aide d'un densitomètre MACBETH RD 914.
The checks carried out on the microcapsules as well as on the CB papers obtained by coating these microcapsules are collated in the table below.
  • . The particle size control is carried out using a laser granulometer (Coulter LS 100). The mean diameter and the size dispersion characterized by the variance are determined.
  • . The viscosity is measured using a HAAKE VT 181 viscometer with mobile MV1,
  • . The dry matter rate using an infrared desiccator (the internal phase is counted as dry matter),
  • . The degree of encapsulation is measured by coating the microcapsules on CF paper and then crushing under 500 bar of pressure on half of the sheet. The difference in optical density between the crushed part and the non-crushed part is then measured using a MACBETH RD 914 densitometer.

Ces contrôles sont complétés par une série de tests complémentaires :

  • . La sensibilité au maculage sous faible pression. On écrase une liasse (CB + CF) sous 50 bars puis on mesure la perte de blancheur du CF à l'aide d'un réflectomètre Docteur Lange.
  • . La réactivité du CB par écrasement à la calandre d'une liasse (CB + CF) et mesure de la densité optique de la coloration obtenue après une heure d'attente à l'abri de la lumière.
  • . La résistance à la lumière de l'écriture par exposition aux UV (lampe à mercure de 400 W). On mesure la chute de la densité optique après 3 heures d'exposition.
  • . Les tests de vieillissement accélérés des feuillets CB
    • soit en chaleur sèche : 72 heures à 140°C sous un poids de 5 kg,
    • soit en chaleur humide : 5 jours à 80°C et 80 % d'humidité relative sous un poids de 5 kg ; feuillet CB contre feuillet CF.
These checks are supplemented by a series of additional tests:
  • . Sensitivity to smearing under low pressure. A bundle (CB + CF) is crushed under 50 bars and then the loss of whiteness of the CF is measured using a Doctor Lange reflectometer.
  • . The reactivity of the CB by crushing with a calender of a bundle (CB + CF) and measurement of the optical density of the coloration obtained after an hour of waiting in the dark.
  • . The resistance to light of writing by UV exposure (400 W mercury lamp). The drop in optical density is measured after 3 hours of exposure.
  • . Accelerated aging tests for CB sheets
    • either in dry heat: 72 hours at 140 ° C under a weight of 5 kg,
    • either in humid heat: 5 days at 80 ° C and 80% relative humidity under a weight of 5 kg; CB slip versus CF slip.

Dans les deux cas, on mesure la perte de réactivité du CB par écrasement à la calandre avant et après vieillissement. De plus, dans le cas du test en chaleur humide, on mesure la perte de blancheur du CF due à la migration d'une partie des agents chromogènes présents dans les microcapsules par rapport à un essai à blanc sur le même CF.

Figure imgb0001
In both cases, the loss of reactivity of the CB is measured by crushing with the calender before and after aging. In addition, in the case of the moist heat test, the loss of whiteness of the CF due to the migration of part of the chromogenic agents present in the microcapsules is measured compared to a blank test on the same CF.
Figure imgb0001

Claims (11)

Microcapsule utile notamment pour papier copiant sensible à la pression, contenant une solution organique d'un agent chromogène hydrophobe, caractérisée en ce que le solvant comprend un mélange obtenu par transestérification d'une huile végétale.Microcapsule useful in particular for pressure-sensitive copying paper, containing an organic solution of a hydrophobic chromogenic agent, characterized in that the solvent comprises a mixture obtained by transesterification of a vegetable oil. Microcapsule selon la revendication 1, caractérisée en ce que l'huile végétale est choisie dans le groupe constitué par les huiles de colza, soja, lin, coprah, palme, maïs, tournesol, olive, arachide, palmiste.Microcapsule according to claim 1, characterized in that the vegetable oil is chosen from the group consisting of rapeseed, soybean, flax, copra, palm, corn, sunflower, olive, peanut, palm kernel oils. Microcapsule selon la revendication 1, caractérisée en ce que le reste alcool de l'ester du mélange est un reste alcool linéaire ou ramifié de C₁ à C₁₀.Microcapsule according to claim 1, characterized in that the alcohol residue of the ester of the mixture is a linear or branched alcohol residue from C₁ to C₁₀. Microcapsule selon la revendication 3, caractérisée en ce que le reste alcool est le reste des alcools suivants : méthanol, éthanol, n-propanol, isopropanol, n-butanol, isobutanol, t-butanol.Microcapsule according to claim 3, characterized in that the alcohol residue is the rest of the following alcohols: methanol, ethanol, n-propanol, isopropanol, n-butanol, isobutanol, t-butanol. Microcapsule selon l'une des revendications 1 à 4, caractérisée en ce que le solvant comprend au moins 30 % en poids d'ester obtenu par transestérification d'une huile végétale.Microcapsule according to one of claims 1 to 4, characterized in that the solvent comprises at least 30% by weight of ester obtained by transesterification of a vegetable oil. Microcapsule selon la revendication 5, caractérisée en ce que le solvant comprend en pourcentage en poids : - mélange obtenu par transestérification d'une huile végétale   30 à 100 % - huile minérale   0 à 70 % Microcapsule according to claim 5, characterized in that the solvent comprises, in percentage by weight: - mixture obtained by transesterification of a vegetable oil 30 to 100% - mineral oil 0 to 70% Microcapsule selon la revendication 6, caractérisée en ce que le solvant comprend en pourcentage en poids : - mélange obtenu par transestérification d'une huile végétale   30 à 50 % - huile minérale   50 à 70 % Microcapsule according to claim 6, characterized in that the solvent comprises, in percentage by weight: - mixture obtained by transesterification of a vegetable oil 30 to 50% - mineral oil 50 to 70% Microcapsule selon la revendication 6 ou 7, caractérisée en ce que l'huile minérale est choisie parmi les kérosènes, les huiles paraffiniques ou naphténiques.Microcapsule according to claim 6 or 7, characterized in that the mineral oil is chosen from kerosene, paraffinic or naphthenic oil. Microcapsule selon l'une des revendications 1 à 8, caractérisée en ce que l'agent chromogène est choisie dans le groupe constitué par les dérivés du type phtalique comme le 3,3-bis(4-diméthylamino- phényl)-6-diméthylamino-phtalide (CVL) et le 3,3-bis(1-octyl-2-méthylindole-3-yle)phtalide ou des dérivés de fluorane comme les 2-anilino-3 méthyl-6-dialkylamino -2'-(N'-éthyl-N-phénylamino-4'-méthylfluorane) ou le 2'-anilino-3' méthyl-6 diéthylamino fluorane, le 6'-diméthylamino-2'-(N-éthyl-N-phénylamino-4'-méthylfluorane), le 3'-chloro-6'-cyclohexylaminofluorane ou le 3,7-bis(diméthylamino)-10-benzoylphenotiazine (BLMB) et les composés de bisarylcarbazolylméthane.Microcapsule according to one of Claims 1 to 8, characterized in that the chromogenic agent is chosen from the group consisting of derivatives of the phthalic type such as 3,3-bis (4-dimethylamino-phenyl) -6-dimethylamino- phthalide (CVL) and 3,3-bis (1-octyl-2-methylindole-3-yl) phthalide or fluorane derivatives such as 2-anilino-3 methyl-6-dialkylamino -2 '- (N'- ethyl-N-phenylamino-4'-methylfluorane) or 2'-anilino-3 ' 6-methyl diethylamino fluorane, 6'-dimethylamino-2 '- (N-ethyl-N-phenylamino-4'-methylfluorane), 3'-chloro-6'-cyclohexylaminofluorane or 3,7-bis (dimethylamino) -10-benzoylphenotiazine (BLMB) and bisarylcarbazolylmethane compounds. Papier sensible à la pression revêtu sur une face d'une couche de microcapsule selon l'une des revendications 1 à 9.Pressure-sensitive paper coated on one side with a layer of microcapsule according to one of claims 1 to 9. Liasse de papier sensible à la pression comportant au moins un papier selon la revendication 10.Bundle of pressure-sensitive paper comprising at least one paper according to claim 10.
EP19950401746 1994-07-26 1995-07-24 New organic solvent for microcapsules useful notably for pressure-sensitive copy paper and pressure-sensitive copy coated with such microcapsules Expired - Lifetime EP0697293B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9409220A FR2723032B1 (en) 1994-07-26 1994-07-26 NOVEL ORGANIC SOLVENT FOR MICROCAPSULES USEFUL IN PARTICULAR FOR PRODUCING PRESSURE SENSITIVE SELF-COPYING PAPER AND LAPRESSION SENSITIVE PAPER COATED WITH SUCH MICROCAPSULES
FR9409220 1994-07-26

Publications (2)

Publication Number Publication Date
EP0697293A1 true EP0697293A1 (en) 1996-02-21
EP0697293B1 EP0697293B1 (en) 1998-09-09

Family

ID=9465741

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19950401746 Expired - Lifetime EP0697293B1 (en) 1994-07-26 1995-07-24 New organic solvent for microcapsules useful notably for pressure-sensitive copy paper and pressure-sensitive copy coated with such microcapsules

Country Status (3)

Country Link
EP (1) EP0697293B1 (en)
DE (1) DE69504612T2 (en)
FR (1) FR2723032B1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999002349A2 (en) * 1997-07-07 1999-01-21 Cognis Deutschland Gmbh Use of alkoxylated fatty acid low alkyl esters
WO2000016985A1 (en) * 1998-09-23 2000-03-30 The Mead Corporation Microcapsules comprising solvent for chromogenic material
EP1136277A2 (en) * 2000-03-07 2001-09-26 Appleton Papers Inc. Record material

Citations (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2712507A (en) 1953-06-30 1955-07-05 Ncr Co Pressure sensitive record material
US2730457A (en) 1953-06-30 1956-01-10 Ncr Co Pressure responsive record materials
US3016308A (en) 1957-08-06 1962-01-09 Moore Business Forms Inc Recording paper coated with microscopic capsules of coloring material, capsules and method of making
JPS4931414A (en) * 1972-07-05 1974-03-20
FR2458313A1 (en) 1979-06-08 1981-01-02 Kanzaki Paper Mfg Co Ltd DISPERSIONS OF MICROCAPSULES
EP0086636A1 (en) 1982-02-13 1983-08-24 Appleton Papers Inc. Pressure sensitive record systems
US4402856A (en) 1980-04-26 1983-09-06 Bayer Aktiengesellschaft Microcapsules with a defined opening temperature, a process for their production and their use
US4406816A (en) 1979-10-08 1983-09-27 Basf Aktiengesellschaft Process for the preparation of microcapsules, and the microcapsules obtained thereby
US4422670A (en) 1981-02-12 1983-12-27 Jujo Paper Co., Ltd. Color developing sheet for pressure-sensitive recording sheet
US4444699A (en) 1982-04-20 1984-04-24 Appleton Papers Inc. Capsule manufacture
EP0155593A2 (en) 1984-03-09 1985-09-25 Kanzaki Paper Manufacturing Co., Ltd Fluoran compounds and recording sheets containing them
US4559242A (en) 1983-02-23 1985-12-17 Fuji Photo Film Co., Ltd. Method of preparing color developer sheets
FR2581350A1 (en) 1985-05-02 1986-11-07 Wiggins Teape Group Ltd RECORDING MATERIAL CARRYING A REVELATORY OR COLOR DEVELOPING COMPOSITION
US4668580A (en) 1984-06-13 1987-05-26 Bayer Aktiengesellschaft Continuous production of microcapsule dispersions
FR2591124A1 (en) 1985-12-10 1987-06-12 Rhone Poulenc Spec Chim METHOD FOR MICROENCAPSULATION BY POLYADDITION-INTERFACIAL.
EP0262569A2 (en) 1986-09-30 1988-04-06 Stora Feldmühle Aktiengesellschaft Pressure-sensitive recording material
US4769305A (en) 1983-11-16 1988-09-06 Fuji Photo Film Co., Ltd. Pressure-sensitive recording material
US4783196A (en) 1986-02-21 1988-11-08 Bayer Aktiengesellshcaft Highly concentrated stable solutions of color-forming agents: for pressure-sensitive recording materials
US4785048A (en) 1988-02-08 1988-11-15 Moore Business Forms, Inc. Polyurea and polyurea-epoxy microcapsules
EP0319337A1 (en) 1987-12-03 1989-06-07 The Mead Corporation Producing microcapsules and an imaging sheet utilising such microcapsules
EP0339866A2 (en) 1988-04-23 1989-11-02 The Wiggins Teape Group Limited A process for the production of microcapsules
US4898696A (en) 1985-09-14 1990-02-06 Basf Aktiengesellschaft Continuous preparation of microcapsules with melamine-formaldehyde condensate walls in aqueous dispersion
US4898780A (en) 1985-11-08 1990-02-06 The Standard Register Company Production of microcapsules
EP0444559A1 (en) 1990-03-02 1991-09-04 Papierfabrik August Koehler AG Process for producing microcapsules
US5075279A (en) 1988-06-15 1991-12-24 Fuji Photo Film Co., Ltd. Method for the manufacture of microcapsules for pressure-sensitive recording sheets
EP0486745A1 (en) * 1990-11-20 1992-05-27 Monsanto Europe S.A./N.V. Improved solvents for chromogens useful in the manufacture of carbonless copying paper
EP0520639A1 (en) 1991-06-18 1992-12-30 The Wiggins Teape Group Limited Solvent compositions for use in pressure-sensitive copying paper
EP0593192A2 (en) 1992-10-15 1994-04-20 The Wiggins Teape Group Limited Chromogenic composition for use in pressure-sensitive record material

Patent Citations (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2730457A (en) 1953-06-30 1956-01-10 Ncr Co Pressure responsive record materials
US2712507A (en) 1953-06-30 1955-07-05 Ncr Co Pressure sensitive record material
US3016308A (en) 1957-08-06 1962-01-09 Moore Business Forms Inc Recording paper coated with microscopic capsules of coloring material, capsules and method of making
JPS4931414A (en) * 1972-07-05 1974-03-20
FR2458313A1 (en) 1979-06-08 1981-01-02 Kanzaki Paper Mfg Co Ltd DISPERSIONS OF MICROCAPSULES
US4406816A (en) 1979-10-08 1983-09-27 Basf Aktiengesellschaft Process for the preparation of microcapsules, and the microcapsules obtained thereby
US4402856A (en) 1980-04-26 1983-09-06 Bayer Aktiengesellschaft Microcapsules with a defined opening temperature, a process for their production and their use
US4422670A (en) 1981-02-12 1983-12-27 Jujo Paper Co., Ltd. Color developing sheet for pressure-sensitive recording sheet
EP0086636A1 (en) 1982-02-13 1983-08-24 Appleton Papers Inc. Pressure sensitive record systems
US4444699A (en) 1982-04-20 1984-04-24 Appleton Papers Inc. Capsule manufacture
US4559242A (en) 1983-02-23 1985-12-17 Fuji Photo Film Co., Ltd. Method of preparing color developer sheets
US4769305A (en) 1983-11-16 1988-09-06 Fuji Photo Film Co., Ltd. Pressure-sensitive recording material
EP0155593A2 (en) 1984-03-09 1985-09-25 Kanzaki Paper Manufacturing Co., Ltd Fluoran compounds and recording sheets containing them
US4668580A (en) 1984-06-13 1987-05-26 Bayer Aktiengesellschaft Continuous production of microcapsule dispersions
FR2581350A1 (en) 1985-05-02 1986-11-07 Wiggins Teape Group Ltd RECORDING MATERIAL CARRYING A REVELATORY OR COLOR DEVELOPING COMPOSITION
US4898696A (en) 1985-09-14 1990-02-06 Basf Aktiengesellschaft Continuous preparation of microcapsules with melamine-formaldehyde condensate walls in aqueous dispersion
US4898780A (en) 1985-11-08 1990-02-06 The Standard Register Company Production of microcapsules
FR2591124A1 (en) 1985-12-10 1987-06-12 Rhone Poulenc Spec Chim METHOD FOR MICROENCAPSULATION BY POLYADDITION-INTERFACIAL.
US4783196A (en) 1986-02-21 1988-11-08 Bayer Aktiengesellshcaft Highly concentrated stable solutions of color-forming agents: for pressure-sensitive recording materials
US4923641A (en) 1986-02-21 1990-05-08 Bayer Aktiengesellschaft Highly concentrated stable solutions of color-forming agent: for pressure-sensitive recording materials
EP0262569A2 (en) 1986-09-30 1988-04-06 Stora Feldmühle Aktiengesellschaft Pressure-sensitive recording material
EP0319337A1 (en) 1987-12-03 1989-06-07 The Mead Corporation Producing microcapsules and an imaging sheet utilising such microcapsules
US4785048A (en) 1988-02-08 1988-11-15 Moore Business Forms, Inc. Polyurea and polyurea-epoxy microcapsules
EP0339866A2 (en) 1988-04-23 1989-11-02 The Wiggins Teape Group Limited A process for the production of microcapsules
US5075279A (en) 1988-06-15 1991-12-24 Fuji Photo Film Co., Ltd. Method for the manufacture of microcapsules for pressure-sensitive recording sheets
EP0444559A1 (en) 1990-03-02 1991-09-04 Papierfabrik August Koehler AG Process for producing microcapsules
EP0486745A1 (en) * 1990-11-20 1992-05-27 Monsanto Europe S.A./N.V. Improved solvents for chromogens useful in the manufacture of carbonless copying paper
EP0520639A1 (en) 1991-06-18 1992-12-30 The Wiggins Teape Group Limited Solvent compositions for use in pressure-sensitive copying paper
EP0593192A2 (en) 1992-10-15 1994-04-20 The Wiggins Teape Group Limited Chromogenic composition for use in pressure-sensitive record material

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Week 7432, Derwent World Patents Index; AN 74-57585V *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999002349A2 (en) * 1997-07-07 1999-01-21 Cognis Deutschland Gmbh Use of alkoxylated fatty acid low alkyl esters
WO1999002349A3 (en) * 1997-07-07 2000-09-28 Cognis Deutschland Gmbh Use of alkoxylated fatty acid low alkyl esters
WO2000016985A1 (en) * 1998-09-23 2000-03-30 The Mead Corporation Microcapsules comprising solvent for chromogenic material
EP1136277A2 (en) * 2000-03-07 2001-09-26 Appleton Papers Inc. Record material
EP1136277A3 (en) * 2000-03-07 2003-07-30 Appleton Papers Inc. Record material

Also Published As

Publication number Publication date
DE69504612D1 (en) 1998-10-15
EP0697293B1 (en) 1998-09-09
FR2723032B1 (en) 1996-11-22
FR2723032A1 (en) 1996-02-02
DE69504612T2 (en) 1999-05-27

Similar Documents

Publication Publication Date Title
CA1158437A (en) Pressure sensitive recording materials
CH382771A (en) Process for manufacturing capsules containing a liquid immiscible with water
US5472489A (en) Solvent compositions for use in pressure-sensitive copying paper
EP0697293B1 (en) New organic solvent for microcapsules useful notably for pressure-sensitive copy paper and pressure-sensitive copy coated with such microcapsules
EP0593192B1 (en) Chromogenic composition for use in pressure-sensitive record material
EP0106772A1 (en) Thermographic compositions containing these developers and thermographic copying materials
DE19717651B4 (en) Carbon-free, pressure-sensitive copying paper and its use
US4820550A (en) Process for producing a sheet of color-developer for pressure-sensitive recording paper
EP0714786B1 (en) New microcapsules comprising as solvent a terpene derivative or an abietic acid derivative, notably for chemical copy papers and messure sensitive papers coated with such microcapsules
US20040245661A1 (en) Process for the preparation of microcapsules
LU82045A1 (en) RECORDING RECEIVING SHEET AND MANUFACTURING METHOD THEREOF
FR2718059A1 (en) Process for producing microcapsules with a high solids content containing a hydrophobic liquid, microcapsules obtained by said process and process for obtaining a pressure-sensitive paper using these microcapsules.
US20070014918A1 (en) Process for encapsulating dissolved reactants of color-reaction systems, the capsules obtainable therefrom as well as their use in color-reaction papers
JPH055074A (en) Encapsulated ink composition
JPH03247484A (en) Stilt material and pressure sensitive layer therewith
JP3611094B2 (en) Color former microcapsule
BE829482R (en) PROCESS FOR PRODUCING MICROCAPSULES AND MICROCAPSULES THUS OBTAINED
JPH09502135A (en) Pressure sensitive recording material
JP3633649B2 (en) How to make pressure-sensitive copying paper
JP3611095B2 (en) Color former microcapsule
BE880766A (en) CHROMOGENEOUS SUBSTANCE
JP3844882B2 (en) Pressure sensitive recording material
JPS6049119B2 (en) pressure sensitive recording paper
LU81937A1 (en) SINGLE PRESSURE SENSITIVE CHROMOGENEOUS RECORDING PAPER OF THE SINGLE LAYER TYPE
JPH0415749B2 (en)

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): BE DE GB

17P Request for examination filed

Effective date: 19960805

17Q First examination report despatched

Effective date: 19970401

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: COPIGRAPH

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): BE DE GB

REF Corresponds to:

Ref document number: 69504612

Country of ref document: DE

Date of ref document: 19981015

GBT Gb: translation of ep patent filed (gb section 77(6)(a)/1977)

Effective date: 19981104

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed
REG Reference to a national code

Ref country code: GB

Ref legal event code: IF02

REG Reference to a national code

Ref country code: DE

Ref legal event code: R082

Ref document number: 69504612

Country of ref document: DE

Representative=s name: KILIAN KILIAN & PARTNER, DE

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20140721

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20140721

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BE

Payment date: 20140722

Year of fee payment: 20

REG Reference to a national code

Ref country code: DE

Ref legal event code: R071

Ref document number: 69504612

Country of ref document: DE

REG Reference to a national code

Ref country code: GB

Ref legal event code: PE20

Expiry date: 20150723

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20150723